Xiongfei Yu
Overview
Explore the profile of Xiongfei Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Q, Xiao C, Hu P, Zhang X, Lian J, Su X, et al.
Immunopharmacol Immunotoxicol
. 2025 Jan;
1-7.
PMID: 39819181
Background: The incidence of hepatic immune-related adverse events has increased with the wide use of immune checkpoint inhibitors (ICIs), some immune-mediated hepatotoxicity (IMH) cases are severe and lack of clinical...
2.
Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, et al.
Drug Resist Updat
. 2024 Jun;
76:101101.
PMID: 38897903
No abstract available.
3.
Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, et al.
Drug Resist Updat
. 2024 Apr;
74:101080.
PMID: 38579635
Background: Gastric Cancer (GC) characteristically exhibits heterogeneous responses to treatment, particularly in relation to immuno plus chemo therapy, necessitating a precision medicine approach. This study is centered around delineating the...
4.
Lin W, Zhang Y, Yang Y, Lin B, Zhu M, Xu J, et al.
Adv Sci (Weinh)
. 2023 Aug;
10(30):e2303908.
PMID: 37587833
The majority of patients with human epidermal growth factor receptor 2 (Her2)-positive gastric cancer develop refractory to Her2-targeted therapy, where upregulation of immune checkpoints plays an essential role. Herein, a...
5.
Chen S, Zhang H, Yu X, Chen Y
AME Case Rep
. 2023 May;
7:19.
PMID: 37122965
Background: Meckel's diverticulum is a blind-end true diverticulum that contains all of the layers, which is normally found in the ileum. Prevalence of Meckel's diverticulum is around 2% in the...
6.
Yu X, Chen Y, Lu J, He K, Chen Y, Ding Y, et al.
Front Oncol
. 2022 Dec;
12:985154.
PMID: 36465411
Background: Patient-derived xenograft (PDX) models have shown a great efficiency in preclinical and translational applications. Gastrointestinal (GI) tumors have a strong heterogeneity, and the engraftment rate of PDX models remarkably...
7.
Jiang H, Yu X, Li N, Kong M, Ma Z, Zhou D, et al.
J Immunother Cancer
. 2022 Mar;
10(3).
PMID: 35296556
Immune checkpoint inhibitors have greatly improved the prognoses of diverse advanced malignancies, including gastric and gastroesophageal junction (G/GEJ) cancer. However, the role of anti-programmed cell death protein-1 treatment in the...
8.
Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, et al.
Clin Transl Med
. 2022 Feb;
12(2):e730.
PMID: 35184420
Background: Deciphering intra- and inter-tumoural heterogeneity is essential for understanding the biology of gastric cancer (GC) and its metastasis and identifying effective therapeutic targets. However, the characteristics of different organ-tropism...
9.
Yang Y, Huang Y, Lin W, Liu J, Chen X, Chen C, et al.
J Transl Med
. 2022 Jan;
20(1):52.
PMID: 35093110
It is widely acknowledged that gastric cancer seriously affects the quality of life and survival of patients. The correlation between the microbiota and gastric cancer has attracted extensive attention in...
10.
Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, et al.
Nat Commun
. 2021 Jun;
12(1):3946.
PMID: 34168152
Alpha-fetoprotein producing gastric carcinoma (AFPGC) is a rare and aggressive subtype of gastric cancer. However, little is known about the genomic features of this disease. We perform whole-exome sequencing analysis...